Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit ...

Dr. Edmund Folefac, from the Ohio State University Comprehensive Cancer Center, says many Americans are not aware of the symptoms and those warning signs often come when the disease is in later stages ...

Testing the molecular profile of tumors identifies which patients with advanced prostate cancer are more likely to benefit from chemotherapy and live longer, sparing patients less likely to benefit ...

blood test to check for prostate conditions including prostate cancer or an enlarged prostate. Routine PSA testing is not currently offered on the NHS, but patients may be offered a PSA test if a GP ...

ANSWER: Gynecomastia is the growth of male breast tissue, specifically when not due to breast cancer. It can happen during ...

Health officials will review guidance on prostate cancer following concerns that 5,000 men are undergoing needless treatment ...

Testing the molecular profile of prostate tumours identifies which patients with advanced prostate cancer are more likely to benefit from a chemotherapy treatment called docetaxel and live longer, ...

Preexisting depression may have a significant impact on survival for men with prostate cancer.A long-term cohort study found ...

June brought major prostate cancer updates, and CURE is sharing the latest FDA approvals, label expansions, and emerging data on the role of AI in care.

Prostate cancer is one of the most common cancers in men. Although watchful waiting is appropriate for low-risk cases, many are diagnosed at an advanced stage because of racial health disparities.

New research reveals that excess body weight could offer a survival edge for men with metastatic prostate cancer, raising fresh questions about the so-called ‘obesity paradox.’ ...